Oruka Therapeutics, Inc. (ORKA)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
Key ratios (FY2025)
-22.3%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating Income | -$122.05M | — | -$7.30M | -$10.60M | -$19.34M | -$9.77M | -$5.81M | -$8.12M | -$18.71M | -$16.61M |
| Net Income | -$105.43M | — | -$5.34M | -$9.93M | -$19.32M | -$9.74M | -$5.48M | -$7.93M | -$18.49M | -$16.44M |
| EPS (Diluted) | — | — | $-0.37 | $-0.69 | $-1.39 | — | — | — | — | — |
| Total Assets | $488.62M | $396.02M | $37.86M | $43.09M | $54.92M | $50.43M | $8.54M | $6.83M | $12.37M | $24.63M |
| Total Liabilities | $16.69M | $13.80M | $841.0K | $1.41M | $3.88M | $3.91M | $926.0K | $793.0K | $2.09M | $2.44M |
| Shareholders' Equity | $471.93M | $382.22M | $37.02M | $41.67M | $51.04M | $46.52M | $7.61M | $6.03M | $10.28M | $22.19M |
| Cash & Equivalents | $46.94M | $61.58M | $37.43M | $42.45M | $53.36M | $49.07M | $8.36M | $6.61M | $8.70M | $7.40M |
| Operating Cash Flow | -$88.21M | — | -$5.01M | -$10.91M | -$18.76M | -$7.72M | -$4.80M | -$8.24M | -$17.47M | — |
| Capital Expenditures | $209.0K | — | $0 | $2.0K | $43.0K | $19.0K | $4.0K | $4.0K | $3.0K | $12.0K |
| Shares Outstanding | 48.72M | 37.44M | 14.50M | 14.41M | 14.41M | 9.55M | 1.59M | 773.6K | 11.78M | 9.08M |